Utama › Kanser Saluran Pernafasan › Michigan

Kajian klinikal Kanser Saluran Pernafasan di Michigan

4 kajian untuk Kanser Saluran Pernafasan sedang mencari peserta di lokasi di Michigan.

Teks kajian rasmi (Bahasa Inggeris)

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

START Midwest, Grand Rapids

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06128551

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

University of Michigan, Ann Arbor
The Cancer & Hematology Centers, Grand Rapids

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06119581

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Henry Ford Cancer Institute, Detroit

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 1 Sep 2026 · NCT07185997

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor

Mengambil peserta

Umur 18 ke atas · Semua jantina · Dikemas kini 19 Feb 2026 · NCT02984761

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.